Search Results - Sergey Shcherbinin

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Predicting regional tau accumulation with machine learning‐based tau‐PET and advanced radiomics by Saima Rathore, Ixavier A. Higgins, Jian Wang, Ian A. Kennedy, Leonardo Iaccarino, Samantha C. Burnham, Michael J. Pontecorvo, Sergey Shcherbinin

    Get full text
    Article


  2. 2

    Tau-network mapping of domain-specific cognitive impairment in Alzheimer’s disease by Ying Luan, Anna Rubinski, Davina Biel, Diana Otero Svaldi, Ixavier Alonzo Higgins, Sergey Shcherbinin, Michael Pontecorvo, Nicolai Franzmeier, Michael Ewers

    Published in NeuroImage: Clinical (2024-01-01)
    Get full text
    Article


  3. 3

    Preclinical PET Imaging and Toxicity Study of a <sup>68</sup>Ga-Functionalized Polymeric Cardiac Blood Pool Agent by Katayoun Saatchi, François Bénard, Navjit Hundal, Joshua Grimes, Sergey Shcherbinin, Maral Pourghiasian, Donald E. Brooks, Anna Celler, Urs O. Häfeli

    Published in Pharmaceutics (2023-02-01)
    Get full text
    Article


  4. 4

    Donanemab exposure and efficacy relationship using modeling in Alzheimer's disease by Ivelina Gueorguieva, Brian A. Willis, Laiyi Chua, Kay Chow, C. Steven Ernest II, Jian Wang, Sergey Shcherbinin, John R. Sims, Emmanuel Chigutsa

    Get full text
    Article


  5. 5

    Magnetic resonance imaging measures of brain volumes across the EXPEDITION trials in mild and moderate Alzheimer's disease dementia by Diana Otero Svaldi, Ixavier A. Higgins, Karen C. Holdridge, Roy Yaari, Michael Case, Luc Bracoud, David Scott, Sergey Shcherbinin, John R. Sims

    Get full text
    Article


  6. 6

    Regional tau PET patterns predict prospective domain-specific cognitive decline in early symptomatic Alzheimer’s disease by Maura Malpetti, Saima Rathore, Leonardo Iaccarino, Renaud La Joie, Giulia Tronchin, Alette M. Wessels, John R. Sims, Michael J. Pontecorvo, Sergey Shcherbinin, Gil D. Rabinovici

    Published in Alzheimer’s Research & Therapy (2025-10-01)
    Get full text
    Article


  7. 7

    Detection of alpha-rod protein repeats using a neural network and application to huntingtin. by Gareth A Palidwor, Sergey Shcherbinin, Matthew R Huska, Tamas Rasko, Ulrich Stelzl, Anup Arumughan, Raphaele Foulle, Pablo Porras, Luis Sanchez-Pulido, Erich E Wanker, Miguel A Andrade-Navarro

    Published in PLoS Computational Biology (2009-03-01)
    Get full text
    Article


  8. 8

    Tau as a diagnostic instrument in clinical trials to predict amyloid in Alzheimer's disease by Sergey Shcherbinin, Amanda Morris, Ixavier A. Higgins, Ilke Tunali, Ming Lu, Carmen Deveau, Sudeepti Southekal, Vikas Kotari, Cynthia D. Evans, Anupa K. Arora, Emily C. Collins, Michael Pontecorvo, Mark A. Mintun, John R. Sims

    Get full text
    Article


  9. 9

    Combining tau-PET and fMRI meta-analyses for patient-centered prediction of cognitive decline in Alzheimer’s disease by Davina Biel, Ying Luan, Matthias Brendel, Paul Hager, Anna Dewenter, Alexis Moscoso, Diana Otero Svaldi, Ixavier A. Higgins, Michael Pontecorvo, Sebastian Römer, Anna Steward, Anna Rubinski, Lukai Zheng, Michael Schöll, Sergey Shcherbinin, Michael Ewers, Nicolai Franzmeier, the Alzheimer’s Disease Neuroimaging Initiative

    Published in Alzheimer’s Research & Therapy (2022-11-01)
    Get full text
    Article


  10. 10

    Discovery and clinical translation of ceperognastat, an O‐GlcNAcase (OGA) inhibitor, for the treatment of Alzheimer's disease by William Kielbasa, Paul Goldsmith, Kevin B. Donnelly, Hugh N. Nuthall, Sergey Shcherbinin, Adam S. Fleisher, Jörg Hendle, Susan L. DuBois, Stephen L. Lowe, Feiyu Fred Zhang, Eric M. Woerly, Nicolas J.‐F. Dreyfus, David Evans, Jeremy Gilmore, Michele Mancini, Cristian C. Constantinescu, Roger N. Gunn, David S. Russell, Emily C. Collins, Miroslaw Brys, Michael L. Hutton, Dustin J. Mergott

    Get full text
    Article


  11. 11

    CYP1B1-RMDN2 Alzheimer’s disease endophenotype locus identified for cerebral tau PET by Kwangsik Nho, Shannon L. Risacher, Liana G. Apostolova, Paula J. Bice, Jared R. Brosch, Rachael Deardorff, Kelley Faber, Martin R. Farlow, Tatiana Foroud, Sujuan Gao, Thea Rosewood, Jun Pyo Kim, Kelly Nudelman, Meichen Yu, Paul Aisen, Reisa Sperling, Basavaraj Hooli, Sergey Shcherbinin, Diana Svaldi, Clifford R. Jack, William J. Jagust, Susan Landau, Aparna Vasanthakumar, Jeffrey F. Waring, Vincent Doré, Simon M. Laws, Colin L. Masters, Tenielle Porter, Christopher C. Rowe, Victor L. Villemagne, Logan Dumitrescu, Timothy J. Hohman, Julia B. Libby, Elizabeth Mormino, Rachel F. Buckley, Keith Johnson, Hyun-Sik Yang, Ronald C. Petersen, Vijay K. Ramanan, Nilüfer Ertekin-Taner, Prashanthi Vemuri, Ann D. Cohen, Kang-Hsien Fan, M. Ilyas Kamboh, Oscar L. Lopez, David A. Bennett, Muhammad Ali, Tammie Benzinger, Carlos Cruchaga, Diana Hobbs, Philip L. De Jager, Masashi Fujita, Vaishnavi Jadhav, Bruce T. Lamb, Andy P. Tsai, Isabel Castanho, Jonathan Mill, Michael W. Weiner, for the Alzheimer’s Disease Neuroimaging Initiative (ADNI), the Department of Defense Alzheimer’s Disease Neuroimaging Initiative (DoD-ADNI), the Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Study (A4 Study) and Longitudinal Evaluation of Amyloid Risk and Neurodegeneration (LEARN), the Australian Imaging, Biomarker & Lifestyle Study (AIBL), Andrew J. Saykin

    Published in Nature Communications (2024-09-01)
    Get full text
    Article


Search Tools: